Overview

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-09-17
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).
Phase:
PHASE2
Details
Lead Sponsor:
PDFE Pharma Innovations FZCO
Treatments:
Minoxidil
Solutions